Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ob/Gyn Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ob/Gyn Other
    Breastfeeding May Protect Women From Metabolic Syndrome - (DGNews)
    FDA Approves Low-Dose Local Oestrogen Therapy for the Treatment of Atrophic Vaginitis Due to Menopause - (DGNews)
    MRI Pinpoints Placenta Accreta With High Specificity: Presented at RSNA - (DGDispatch)
    Blood Test Can Reduce Repeat Breast MRI in Women With Irregular Menstrual Cycles - (DGNews)
    Flibanserin Provides Multiple Benefits in Women With Low Sexual Desire: Presented at ESSM - (DGDispatch)

    News archive

     Recent webcasts/CME - Ob/Gyn Other
    • Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Present and the Future
    • Taking Stock of the Current Research: Which New Therapies Are Showing Promise in Ovarian Cancer?
    • Q&A Lightning Round: Expert Opinions on Unanswered Questions and Controversies in Ovarian Cancer
    • Update on DVT and PE in OB Gyn/Ortho Patients
      Hypoactive Sexual Desire Disorder in Women: Implications for Family Practice

      Webcasts/CME archive

       Recent cases - Ob/Gyn Other
        Effects of Growth Hormone Reduction in a Patient with Polycystic Ovary Syndrome Complicated with Acromegaly
        Endometriosis Presenting as an Acute Groin Swelling: A Case Report
        Giant Ovarian Serous Cystadenoma in a Postmenopausal Woman: A Case Report
        Failure of Ultrasound to Diagnose a Giant Ovarian Cyst: A Case Report
        Female Sexual Dysfunction

        Cases archive
          




        my personal edition > ob/gyn other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Survival Better Among Endometrial Cancer Patients Whose Treatment is Delayed

        British Medical Journal (BMJ)

        07/25/2002
        By Harvey McConnell


        Scottish women who had to wait the longest for treatment of their endometrial cancer have had the highest rates of survival.

        This is paradoxical, admits Dr. Simon Crawford and colleagues at the Department of Gynaecological Oncology, Stobhill Hospital, Glasgow, Scotland. "The traditional view is that delay caused by organizational defects has an adverse effect on the disease: this influences survival. Our study suggests that disease influences delay, and so delay is a confounding factor."

        One key may be how the family relays information to the relevant hospital oncologist, and how the oncologist interprets it.

        Few studies have linked delay in treatment with survival, the researchers note, although a study from Israel found that survival from endometrial cancer was not affected by a delay in treatment of four months.

        Researchers collected data from the case notes of 703 women resident in Scotland who were diagnosed between January 1, 1996 and December 31, 1997 as having endometrial cancer.

        Calculations were then made of the time between referral to a hospital oncologist and the time of clinic appointments, investigations, and surgery.

        Each woman in the study was allocated an International Federation of Gynecology and Obstetrics (FIGO) stage of their disease. The median interval from referral to definitive operation varied from 46 to 81 days (74 to 287 days).

        Dr Crawford and colleagues found that delay and survival were inversely related: women with the shortest delay had more advanced disease and survival was least likely among this group of patients.

        This interaction is partially accounted for by the relation between stage and delay, the researchers add. However, a hazards model corrected for age, stage, and use of radiotherapy, again shows it is only partly explained by the FIGO stage category.

        The fact that the strongest effect between delay and survival is seen in the interval between referral and the first hospital visit, suggests that the way family doctors communicate information to hospital oncologists may be crucial.

        Dr Crawford and colleagues said the communication apparently ensures that the oncologists respond faster to patients who are at higher risk. Oncologists "seem to be able, from first clinic visit, to differentiate patients at greater risk and to ensure that cancer is diagnosed and treated faster."

        Women with the longest delays have the best survival, and vice versa, suggesting that the "healing art" remains an important but elusive factor, they conclude.
        BMJ 2002;325:196.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send